E. Gałecka

发表

Vascular endothelial growth factor gene (VEGFA) polymorphisms may serve as prognostic factors for recurrent depressive disorder development

M. Maes, A. Lewiński, M. Talarowska, 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment

J. Szemraj, M. Bieńkiewicz, A. Florkowski, 2009, Pharmacological reports : PR.

Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients

J. Szemraj, M. Bieńkiewicz, P. Gałecki, 2009, Human psychopharmacology.

The expression of genes encoding for COX-2, MPO, iNOS, and sPLA2-IIA in patients with recurrent depressive disorder.

M. Maes, A. Lewiński, J. Szemraj, 2012, Journal of affective disorders.

Single nucleotide polymorphisms of NR3C1 gene and recurrent depressive disorder in population of Poland

A. Lewiński, I. Majsterek, J. Szemraj, 2012, Molecular Biology Reports.

Association of serum deiodinase type 2 level with chronic obstructive pulmonary disease in the Polish population.

P. Górski, E. Gałecka, A. Kumor-Kisielewska, 2019, Acta biochimica Polonica.

Evaluation of NDRG2 gene expression in primary papillary thyroid carcinoma and in metastases of this neoplasm to regional lymph nodes

A. Lewiński, T. Ferenc, A. Zygmunt, 2010, Thyroid research.

Relative quantification of PIK3CA gene expression level in fine-needle aspiration biopsy thyroid specimens collected from patients with papillary thyroid carcinoma and non-toxic goitre by real-time RT-PCR

A. Lewiński, A. Zygmunt, Katarzyna Wojciechowska-Durczynska, 2010, Thyroid research.

ROS GENERATION AND LIPID PEROXIDATION IN PROFESSIONAL SPORTSMEN (EXTREME SPORTS CONDITION)

E. Miller, M. Mrowicka, K. Malinowska, 2008 .

[Lipid peroxidation and copper-zinc superoxide dismutase activity in patients treated with fluoxetine during the first episode of depression].

A. Florkowski, P. Gałecki, J. Kȩdziora, 2007, Psychiatria polska.

Is there a link between TNF gene expression and cognitive deficits in depression?

M. Talarowska, J. Szemraj, P. Gałecki, 2017, Acta biochimica Polonica.

[Activity of superoxide dismutase (CuZn-SOD) in erythrocytes of patients after hips alloplasty].

E. Miller, M. Mrowicka, E. Gałecka, 2008, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.

Expression levels of interferon-γ and type 2 deiodinase in patients diagnosed with recurrent depressive disorders

M. Maes, M. Talarowska, J. Szemraj, 2018, Pharmacological reports : PR.

Single‐nucleotide polymorphisms and mRNA expression for melatonin synthesis rate‐limiting enzyme in recurrent depressive disorder

A. Lewiński, J. Szemraj, G. Bartosz, 2010, Journal of pineal research.

Vascular endothelial growth factor receptor 2 gene (KDR) polymorphisms and expression levels in depressive disorder.

M. Maes, A. Lewiński, M. Talarowska, 2013, Journal of affective disorders.

Assessment of serum levels of DIO1 and DIO3 in patients diagnosed with COPD.

P. Górski, E. Gałecka, A. Kumor-Kisielewska, 2019, Advances in medical sciences.

[Antioxidative enzymes--structure, properties, functions].

A. Florkowski, P. Gałecki, R. Jacewicz, 2008, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.

Association between inducible and neuronal nitric oxide synthase polymorphisms and recurrent depressive disorder.

M. Maes, A. Lewiński, J. Szemraj, 2011, Journal of affective disorders.

Single nucleotide polymorphisms and mRNA expression for melatonin MT2 receptor in depression

A. Lewiński, J. Szemraj, M. Karbownik-Lewińska, 2011, Psychiatry Research.

Association of the DIO2 gene single nucleotide polymorphisms with recurrent depressive disorder.

M. Talarowska, J. Szemraj, P. Górski, 2015, Acta biochimica Polonica.

Polymorphisms of iodothyronine deiodinases (DIO1, DIO3) genes are not associated with recurrent depressive disorder

M. Maes, M. Talarowska, J. Szemraj, 2016, Pharmacological reports : PR.

Polymorphisms in the type I deiodinase gene and frontal function in recurrent depressive disorder.

M. Talarowska, J. Szemraj, P. Górski, 2016, Advances in medical sciences.

Single nucleotide polymorphisms of NR3C1 gene and recurrent depressive disorder in population of Poland

A. Lewiński, I. Majsterek, J. Szemraj, 2012, Molecular Biology Reports.

COX-2 expression in papillary thyroid carcinoma (PTC) in cytological material obtained by fine needle aspiration biopsy (FNAB)

A. Lewiński, Z. Adamczewski, A. Cyniak-Magierska, 2011, Thyroid research.

Effects of imidazenil, a new benzodiazepine receptor partial agonist, in the treatment of convulsions in organophosphate intoxications

M. Kowalczyk, S. Rump, O. Antkowiak, 2009, Neurotoxicity Research.

An inducible nitric oxide synthase polymorphism is associated with the risk of recurrent depressive disorder

M. Maes, A. Lewiński, J. Szemraj, 2010, Neuroscience Letters.

Assessment of type 1 and type 3 deiodinase expression levels in depressive disorders.

M. Maes, J. Szemraj, P. Górski, 2017, Acta neurobiologiae experimentalis.

Thiol protein groups correlate with cognitive impairment in patients with recurrent depressive disorder.

A. Lewiński, E. Kowalczyk, M. Talarowska, 2013, Neuro endocrinology letters.

Effects of CGS 9896 in acute experimental intoxication with fluostigmine

S. Rump, E. Gałecka, T. Gidynska, 2005, Archives of Toxicology.

Single nucleotide polymorphism of the KIBRA gene in recurrent depressive disorders.

A. Lewiński, M. Talarowska, J. Szemraj, 2010, Neuro endocrinology letters.

Working memory impairment as a common component in recurrent depressive disorder and certain somatic diseases.

D. Moczulski, A. Lewiński, M. Talarowska, 2013, Neuro endocrinology letters.

[Role of free radicals in the physiological processes].

P. Gałecki, M. Mrowicka, K. Malinowska, 2008, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.